Heron Therapeutics IncNASDAQ:HRTX
- LAST PRICE3.6900
- TODAY'S CHANGE (%)0.0500 (1.3736%)
- Bid / Lots3.6800/ 23
- Ask / Lots3.6900/ 17
- Open / Previous Close3.7800 / 3.6400
- Day Range
- 52 Week Range
- Volume870,388
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HRTX |
|---|---|---|
| 09:32 ET | 100963 | 3.86 |
| 09:34 ET | 47001 | 3.87 |
| 09:36 ET | 2580 | 3.87 |
| 09:38 ET | 22842 | 3.76 |
| 09:39 ET | 18708 | 3.7823 |
| 09:41 ET | 3820 | 3.78 |
| 09:43 ET | 14278 | 3.79 |
| 09:45 ET | 3725 | 3.785 |
| 09:48 ET | 4198 | 3.795 |
| 09:50 ET | 47506 | 3.81 |
| 09:52 ET | 4589 | 3.79 |
| 09:54 ET | 3843 | 3.795 |
| 09:56 ET | 6722 | 3.8 |
| 09:57 ET | 15629 | 3.7901 |
| 09:59 ET | 3060 | 3.795 |
| 10:01 ET | 1799 | 3.795 |
| 10:03 ET | 777 | 3.79 |
| 10:06 ET | 4360 | 3.7699 |
| 10:08 ET | 22627 | 3.75 |
| 10:10 ET | 2924 | 3.765 |
| 10:12 ET | 6441 | 3.745 |
| 10:14 ET | 2878 | 3.75 |
| 10:15 ET | 2386 | 3.765 |
| 10:17 ET | 1250 | 3.765 |
| 10:19 ET | 250 | 3.765 |
| 10:21 ET | 321 | 3.76 |
| 10:24 ET | 359 | 3.76 |
| 10:26 ET | 1521 | 3.7695 |
| 10:28 ET | 5325 | 3.775 |
| 10:30 ET | 7881 | 3.76 |
| 10:32 ET | 3440 | 3.75 |
| 10:33 ET | 1857 | 3.75 |
| 10:35 ET | 766 | 3.75 |
| 10:37 ET | 1800 | 3.755 |
| 10:39 ET | 1304 | 3.75 |
| 10:42 ET | 5059 | 3.73 |
| 10:44 ET | 26623 | 3.715 |
| 10:46 ET | 1500 | 3.715 |
| 10:48 ET | 100 | 3.71 |
| 10:50 ET | 100 | 3.715 |
| 10:51 ET | 6007 | 3.715 |
| 10:53 ET | 848 | 3.735 |
| 10:55 ET | 605 | 3.74 |
| 10:57 ET | 400 | 3.745 |
| 11:00 ET | 743 | 3.745 |
| 11:02 ET | 8599 | 3.73 |
| 11:04 ET | 500 | 3.725 |
| 11:06 ET | 14989 | 3.745 |
| 11:08 ET | 600 | 3.74 |
| 11:09 ET | 2700 | 3.745 |
| 11:11 ET | 3571 | 3.765 |
| 11:13 ET | 200 | 3.765 |
| 11:15 ET | 2560 | 3.76 |
| 11:18 ET | 2288 | 3.775 |
| 11:20 ET | 200 | 3.775 |
| 11:22 ET | 100 | 3.775 |
| 11:24 ET | 6692 | 3.7668 |
| 11:26 ET | 1969 | 3.77 |
| 11:27 ET | 1100 | 3.77 |
| 11:29 ET | 6514 | 3.785 |
| 11:31 ET | 4952 | 3.77 |
| 11:33 ET | 500 | 3.78 |
| 11:36 ET | 2698 | 3.772 |
| 11:38 ET | 1800 | 3.77 |
| 11:40 ET | 2767 | 3.785 |
| 11:42 ET | 900 | 3.785 |
| 11:44 ET | 300 | 3.785 |
| 11:49 ET | 900 | 3.785 |
| 11:51 ET | 1100 | 3.785 |
| 11:54 ET | 5357 | 3.77 |
| 11:56 ET | 550 | 3.7748 |
| 11:58 ET | 200 | 3.77 |
| 12:00 ET | 2928 | 3.78 |
| 12:02 ET | 1345 | 3.7779 |
| 12:03 ET | 2333 | 3.775 |
| 12:05 ET | 1500 | 3.775 |
| 12:07 ET | 13306 | 3.75 |
| 12:09 ET | 5005 | 3.735 |
| 12:12 ET | 400 | 3.735 |
| 12:14 ET | 23484 | 3.745 |
| 12:16 ET | 6331 | 3.74 |
| 12:18 ET | 428 | 3.735 |
| 12:20 ET | 1447 | 3.7393 |
| 12:21 ET | 200 | 3.7399 |
| 12:23 ET | 400 | 3.735 |
| 12:25 ET | 227 | 3.735 |
| 12:27 ET | 800 | 3.735 |
| 12:30 ET | 14798 | 3.725 |
| 12:32 ET | 10622 | 3.715 |
| 12:34 ET | 4002 | 3.725 |
| 12:36 ET | 1961 | 3.725 |
| 12:38 ET | 5222 | 3.725 |
| 12:39 ET | 2596 | 3.73 |
| 12:41 ET | 498 | 3.72 |
| 12:43 ET | 200 | 3.7265 |
| 12:45 ET | 800 | 3.725 |
| 12:48 ET | 1300 | 3.72 |
| 12:50 ET | 4011 | 3.725 |
| 12:52 ET | 1600 | 3.725 |
| 12:54 ET | 451 | 3.725 |
| 12:56 ET | 112 | 3.725 |
| 12:57 ET | 100 | 3.725 |
| 12:59 ET | 600 | 3.72 |
| 01:01 ET | 1400 | 3.725 |
| 01:03 ET | 1100 | 3.725 |
| 01:06 ET | 5149 | 3.715 |
| 01:08 ET | 25785 | 3.71 |
| 01:10 ET | 5200 | 3.71 |
| 01:12 ET | 100 | 3.71 |
| 01:14 ET | 100 | 3.71 |
| 01:15 ET | 1800 | 3.7106 |
| 01:17 ET | 696 | 3.715 |
| 01:19 ET | 2893 | 3.71 |
| 01:21 ET | 200 | 3.715 |
| 01:24 ET | 5645 | 3.705 |
| 01:26 ET | 10981 | 3.715 |
| 01:30 ET | 4283 | 3.715 |
| 01:32 ET | 9109 | 3.7 |
| 01:33 ET | 3100 | 3.69 |
| 01:35 ET | 13387 | 3.695 |
| 01:37 ET | 100 | 3.695 |
| 01:39 ET | 3052 | 3.695 |
| 01:42 ET | 631 | 3.695 |
| 01:44 ET | 500 | 3.6901 |
| 01:46 ET | 400 | 3.69 |
| 01:48 ET | 1100 | 3.695 |
| 01:50 ET | 2847 | 3.695 |
| 01:51 ET | 14570 | 3.6813 |
| 01:53 ET | 2582 | 3.684 |
| 01:55 ET | 3037 | 3.675 |
| 01:57 ET | 730 | 3.675 |
| 02:00 ET | 3044 | 3.675 |
| 02:02 ET | 13194 | 3.655 |
| 02:04 ET | 1154 | 3.66 |
| 02:06 ET | 2369 | 3.66 |
| 02:08 ET | 4466 | 3.645 |
| 02:09 ET | 2100 | 3.66 |
| 02:11 ET | 2344 | 3.655 |
| 02:13 ET | 200 | 3.665 |
| 02:15 ET | 3763 | 3.67 |
| 02:20 ET | 506 | 3.675 |
| 02:22 ET | 6991 | 3.6702 |
| 02:24 ET | 685 | 3.665 |
| 02:26 ET | 200 | 3.665 |
| 02:27 ET | 2228 | 3.675 |
| 02:29 ET | 300 | 3.675 |
| 02:31 ET | 10274 | 3.685 |
| 02:33 ET | 6516 | 3.685 |
| 02:36 ET | 1999 | 3.685 |
| 02:38 ET | 2094 | 3.695 |
| 02:40 ET | 1138 | 3.69 |
| 02:42 ET | 1913 | 3.69 |
May 29, 2024
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF(R) Vial Access Needle ("VAN"), from 8:05AM ET on Wednesday May 29, 2024 by Dow Jones
8:05AM ET on Wednesday May 29, 2024 by Dow Jones
May 16, 2024
DJ Heron Therapeutics Price Target Maintained With a $5.00/Share by Needham, from 5:40AM ET on Thursday May 16, 2024 by Dow Jones
5:40AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Heron Therapeutics Inc | 555.9M | -6.0x | --- |
Entrada Therapeutics Inc | 526.3M | 25.6x | --- |
Travere Therapeutics Inc | 553.5M | -1.4x | --- |
Avid Bioservices Inc | 511.6M | -27.4x | --- |
WAVE Life Sciences Ltd | 722.5M | -12.5x | --- |
Y-mAbs Therapeutics Inc | 529.7M | -24.3x | --- |
Company Information
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF and APONVIE. HTX- ZYNRELEF is a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. APONVIE is the IV formulation of a NK1 receptor antagonist indicated for postoperative nausea and vomiting (PONV). Its products are distributed in the United States.
Contact Information
- Headquarters
- 4242 Campus Point Court, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-251-4400
- Fax
- ---
Executives
- Chairman of the Board
- Adam Morgan
- Chief Executive Officer, Director
- Craig Collard
- Chief Financial Officer, Principal Accounting Officer
- Ira Duarte
- Executive Vice President, Chief Development Officer
- William Forbes
- Vice President
- Lisa Peraza
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $555.9M |
|---|---|
Revenue (TTM) | $132.1M |
Shares Outstanding | 150.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.82 |
EPS | $-0.62 |
Book Value | $-0.23 |
P/E Ratio | -6.0x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -62.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
